Related Experiment Videos
Comparative evaluation of a new inhalation anesthetic, BAX-3224, and halothane in Macaca speciosa
Abstract:
Two groups of 8 monkeys were anesthetized with either BAX-3224, a new fluorinated methyl-propyl ether, or with halothane, 3 hours daily for a total of 30 hours. Vomiting incidence was 12.5 percent with BAX-3224 during both induction and recovery, compared with 3.7 percent for halothane during induction and 7 percent for halothane during recovery. Induction time did not change during the course of study with either agent. Respiration was spontaneous and cardiopulmonary function was stable. Electroretinographic (ERG) responses were consistent, flicker-light responses similar, but visual evoked responses (VER) were not present during BAX-3224 anesthesia. A 33 percent incidence of electroencephalographic (EEG) silence occurred with BAX-3224, which was consistent with absence of VER. Hematologic and serum chemistry values were similar for both agents. Serum fluoride ion concentrations, measured before exposure and 4 times during the 10-day study, did not change after administration of either agent. This finding was significant for BAX-3224, a fluorinated ether. No cardiac arrhythmias were observed during BAX-3224 anesthesia, compared with a 17 percent incidence during halothane induction. Recovery time was 32 minutes following BAX-3224 and 14 minutes after halothane. BAX-3224 produced anesthesia similar to that of halothane, did not induce changes incompatible with recovery from anesthesia, and showed great potential as a new volatile liquid anesthetic agent with excellent biologic stability.
Insights
BAX-3224, a novel fluorinated ether anesthetic, demonstrated comparable anesthesia to halothane in monkeys, with a higher vomiting incidence but fewer cardiac arrhythmias. It shows potential as a stable anesthetic agent.
Area of Science:
- Veterinary Anesthesiology
- Pharmacology
- Comparative Medicine
Background:
- Halothane is a widely used volatile anesthetic.
- New anesthetic agents are needed to improve safety and efficacy.
- Fluorinated ethers are a class of compounds explored for anesthetic properties.
Purpose of the Study:
- To evaluate the anesthetic efficacy and safety of BAX-3224, a new fluorinated methyl-propyl ether.
- To compare BAX-3224 with halothane in terms of anesthetic effects and physiological responses in a non-human primate model.
Main Methods:
- Two groups of 8 monkeys were anesthetized with either BAX-3224 or halothane for 3 hours daily over 30 hours.
- Vomiting incidence, induction and recovery times, cardiorespiratory function, electroencephalography (EEG), electroretinography (ERG), visual evoked responses (VER), hematologic and serum chemistry values were monitored.
- Serum fluoride ion concentrations were measured throughout the study.
Main Results:
- BAX-3224 showed a higher vomiting incidence (12.5%) compared to halothane (3.7-7%).
- EEG silence (33%) and absence of VER were observed with BAX-3224, while ERG responses remained consistent.
- BAX-3224 anesthesia resulted in no cardiac arrhythmias, unlike halothane (17% incidence), with a longer recovery time (32 min vs. 14 min).
Conclusions:
- BAX-3224 produced anesthesia similar to halothane with stable cardiorespiratory function.
- BAX-3224 did not induce adverse changes incompatible with recovery and demonstrated excellent biologic stability.
- BAX-3224 shows significant potential as a new volatile liquid anesthetic agent.